Processa Pharmaceuticals, Inc. PCSA Q4 2025 Annual earnings
Reported March 19, 2026 · After market close
EPS-$18.50Miss by $17.00
EPS estimate-$1.50
Next report
Aug 6, 2026 (In 1 week)EPS estimate-$1.00
Versus estimates
Diluted EPS
Ask the moment Processa Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Processa Pharmaceuticals, Inc. report Q4 2025 earnings?
- Processa Pharmaceuticals, Inc. (PCSA) reported Q4 2025 earnings on March 19, 2026 after market close.
- What were Processa Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
- Processa Pharmaceuticals, Inc. reported eps of $-18.50 for Q4 2025.
- Did Processa Pharmaceuticals, Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-1.50 by $17.00.
- How did Processa Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 2400.0% from $-0.74.
- Where can I find Processa Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-011204) directly on SEC EDGAR. The filing index links above go to sec.gov.